Early fast‐acting treatment strategy against generalized myasthenia gravisKimiaki Utsugisawa, Masashi Aoki, Tomihiro Imai et al.|Muscle & Nerve|2016Cited by 75
Response to treatment of myasthenia gravis according to clinical subtypeTetsuya Akaishi, Kimiaki Utsugisawa, Yasushi Suzuki et al.|BMC Neurology|2016Cited by 40
Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorderAkiyuki Uzawa, Satoshi Kuwabara|Authorea|2020Cited by 0